Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio

Abstract Amyloid light chain (AL) cardiomyopathy is the most malignant specific cardiomyopathy. According to international recommendations, it should be ruled out non‐invasively using the serum free light chain (FLC) ratio and immunofixation electrophoresis in both serum and urine. Here, we report o...

Full description

Bibliographic Details
Main Authors: David Zach, Klemens Ablasser, Ewald Kolesnik, Viktoria Hoeller, Friedrich Fruhwald, Florian Prüller, Clemens Reiter, Christine Beham‐Schmid, Rainer Lipp, Peter P. Rainer, Andreas Zirlik, Albert Wölfler, Nicolas Verheyen
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13381
_version_ 1819155508959903744
author David Zach
Klemens Ablasser
Ewald Kolesnik
Viktoria Hoeller
Friedrich Fruhwald
Florian Prüller
Clemens Reiter
Christine Beham‐Schmid
Rainer Lipp
Peter P. Rainer
Andreas Zirlik
Albert Wölfler
Nicolas Verheyen
author_facet David Zach
Klemens Ablasser
Ewald Kolesnik
Viktoria Hoeller
Friedrich Fruhwald
Florian Prüller
Clemens Reiter
Christine Beham‐Schmid
Rainer Lipp
Peter P. Rainer
Andreas Zirlik
Albert Wölfler
Nicolas Verheyen
author_sort David Zach
collection DOAJ
description Abstract Amyloid light chain (AL) cardiomyopathy is the most malignant specific cardiomyopathy. According to international recommendations, it should be ruled out non‐invasively using the serum free light chain (FLC) ratio and immunofixation electrophoresis in both serum and urine. Here, we report on a 69‐year‐old female patient with new‐onset heart failure with mid‐range ejection fraction. Cardiac imaging was highly suggestive of cardiac amyloidosis. Amyloid scintigraphy showed faint myocardial tracer uptake according to Perugini Score 1, but immunofixation was negative and the FLC ratio was normal, despite a slight increase in lambda FLCs. Endomyocardial biopsy revealed advanced myocardial lambda immunoglobulin light chain deposition. Clinically relevant extracardiac amyloid organ infiltration could not be detected. Conclusively, non‐invasive testing can in rare cases fail to exclude isolated AL amyloid cardiomyopathy. We suggest that even slight increases in serum lambda or kappa FLCs should be considered abnormal in suspected cardiac amyloidosis if non‐invasive testing delivers discrepant results.
first_indexed 2024-12-22T15:38:06Z
format Article
id doaj.art-9e1d8438218b4f629a25a241ec26c276
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-22T15:38:06Z
publishDate 2021-08-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-9e1d8438218b4f629a25a241ec26c2762022-12-21T18:21:12ZengWileyESC Heart Failure2055-58222021-08-01843397340210.1002/ehf2.13381Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratioDavid Zach0Klemens Ablasser1Ewald Kolesnik2Viktoria Hoeller3Friedrich Fruhwald4Florian Prüller5Clemens Reiter6Christine Beham‐Schmid7Rainer Lipp8Peter P. Rainer9Andreas Zirlik10Albert Wölfler11Nicolas Verheyen12Division of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaClinical Institute of Medical and Chemical Laboratory Diagnostics Medical University of Graz Graz AustriaDivision of General Radiology, Department of Radiology Medical University of Graz Graz AustriaInstitute of Pathology Medical University of Graz Graz AustriaDivision of Oncology, Department of Internal Medicine Medical University of Graz Graz AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaDivision of Hematology, Department of Internal Medicine Medical University of Graz Graz AustriaDivision of Cardiology, Department of Internal Medicine Medical University of Graz Auenbruggerplatz 15 Graz A‐8036 AustriaAbstract Amyloid light chain (AL) cardiomyopathy is the most malignant specific cardiomyopathy. According to international recommendations, it should be ruled out non‐invasively using the serum free light chain (FLC) ratio and immunofixation electrophoresis in both serum and urine. Here, we report on a 69‐year‐old female patient with new‐onset heart failure with mid‐range ejection fraction. Cardiac imaging was highly suggestive of cardiac amyloidosis. Amyloid scintigraphy showed faint myocardial tracer uptake according to Perugini Score 1, but immunofixation was negative and the FLC ratio was normal, despite a slight increase in lambda FLCs. Endomyocardial biopsy revealed advanced myocardial lambda immunoglobulin light chain deposition. Clinically relevant extracardiac amyloid organ infiltration could not be detected. Conclusively, non‐invasive testing can in rare cases fail to exclude isolated AL amyloid cardiomyopathy. We suggest that even slight increases in serum lambda or kappa FLCs should be considered abnormal in suspected cardiac amyloidosis if non‐invasive testing delivers discrepant results.https://doi.org/10.1002/ehf2.13381Cardiac amyloidosisMonoclonal gammopathyEndomyocardial biopsyLight chain amyloidosisFree light chain
spellingShingle David Zach
Klemens Ablasser
Ewald Kolesnik
Viktoria Hoeller
Friedrich Fruhwald
Florian Prüller
Clemens Reiter
Christine Beham‐Schmid
Rainer Lipp
Peter P. Rainer
Andreas Zirlik
Albert Wölfler
Nicolas Verheyen
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
ESC Heart Failure
Cardiac amyloidosis
Monoclonal gammopathy
Endomyocardial biopsy
Light chain amyloidosis
Free light chain
title Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
title_full Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
title_fullStr Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
title_full_unstemmed Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
title_short Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
title_sort advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
topic Cardiac amyloidosis
Monoclonal gammopathy
Endomyocardial biopsy
Light chain amyloidosis
Free light chain
url https://doi.org/10.1002/ehf2.13381
work_keys_str_mv AT davidzach advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT klemensablasser advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT ewaldkolesnik advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT viktoriahoeller advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT friedrichfruhwald advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT florianpruller advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT clemensreiter advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT christinebehamschmid advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT rainerlipp advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT peterprainer advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT andreaszirlik advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT albertwolfler advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio
AT nicolasverheyen advancedisolatedlightchainamyloidcardiomyopathywithnegativeimmunofixationandnormalfreelightchainratio